A Study to Accelerate Immune System Recovery Following Stem Cell Transplantation

NCT00429039 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

21

Enrollment

OTHER

Sponsor class

Stopped Low accrual.

Conditions

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

Interventions

DRUG: L-leucyl-L-leucine methyl ester (LLME)

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Collaborators

[object Object]